Antengene Corporation Limited announced that the results of the Phase I/II TORCH-2 study will be presented as a poster discussion during the American Society for Clinical Oncology Annual Meeting, taking place from June 2nd to 6th at the McCormick Place Convention Center in Chicago, IL.
